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Abstract
Background: Few trials have compared estimates of change in physical activity (PA) levels using self-reported and
objective PA measures when evaluating trial outcomes. The PACE-UP trial offered the opportunity to assess this,
using the self-administered International Physical Activity Questionnaire (IPAQ) and waist-worn accelerometry.
Methods: The PACE-UP trial (N = 1023) compared usual care (n = 338) with two pedometer-based walking
interventions, by post (n = 339) or with nurse support (n = 346). Participants wore an accelerometer at baseline and
12 months and completed IPAQ for the same 7-day periods. Main outcomes were weekly minutes, all in ≥10 min
bouts as per UK PA guidelines of: i) accelerometer moderate-to-vigorous PA (Acc-MVPA) ii) IPAQ moderate+vigorous
PA (IPAQ-MVPA) and iii) IPAQ walking (IPAQ-Walk). For each outcome, 12month values were regressed on baseline to
estimate change.
Results: Analyses were restricted to 655 (64%) participants who provided data on all outcomes at baseline and 12
months. Both intervention groups significantly increased their accelerometry MVPA minutes/week compared with
control: postal group 42 (95% CI 22, 61), nurse group 43 (95% CI 24, 63). IPAQ-Walk minutes/week also increased: postal
57 (95% CI 2, 112), nurse 43 (95% CI -11, 97) but IPAQ-MVPA minutes/week showed non-significant decreases: postal
-11 (95% CI -65, 42), nurse -34 (95% CI -87, 19).
Conclusions: Our results demonstrate the necessity of using a questionnaire focussing on the activities being altered,
as with IPAQ-Walk questions. Even then, the change in PA was estimated with far less precision than with accelerometry.
Accelerometry is preferred to self-report measurement, minimising bias and improving precision when assessing effects
of a walking intervention.
Trial registration: ISRCTN, ISRCTN98538934. Registered 2 March 2012.
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Background
Adults who participate in regular physical activity (PA)
and remain fit and active into later life have fewer
chronic health conditions, and are better able to main-
tain a healthy weight [1]. WHO, UK and US aerobic PA
guidelines for adults recommend at least 150 min weekly
of moderate-to-vigorous-physical-activity (MVPA) in
bouts of at least 10 min, or 75 min of vigorous PA, or a
combination. Brisk walking (3 miles/hr. or 5 km/hr)
counts as MVPA [2] and for most people approximates
to 1000 steps in 10 min [3].
Self-report questionnaires are a quick, easy way to as-
sess PA. Population surveys such as the Health Survey
for England (HSE) [4] and Sport England’s “Active Lives
Survey” [5] use self-completed questionnaires and report
estimates that around 60% of participants aged 16+ meet
PA guidelines. However, individuals often over-estimate
their PA, particularly walking, on questionnaires com-
pared with accelerometry measures of MVPA [6–8].
Self-report questionnaires can thus lead to inflated esti-
mates of “active” individuals [9].
The International Physical Activity Questionnaire
(IPAQ) short form [10] assesses 7-day recall of PA in
≥10min bouts based on intensity (separating vigorous,
moderate and walking activity) and duration (days per
week and minutes per day). The shorter General Practice
Physical Activity Questionnaire (GPPAQ) [11] does not
provide a continuous measure of PA, but categorises in-
dividuals as active or not. GPPAQ is used in the UK Na-
tional Health Service (NHS) primary care cardiovascular
health checks [12]. Individuals classified as less than “ac-
tive” are assumed not to be meeting PA guidelines and
are offered advice. In contrast, accelerometry is an ob-
jective PA measure, providing information on
step-counts and time spent in different PA intensities
and is increasingly being used in cross-sectional studies
to study PA [13, 14]. Although accelerometers e.g. Acti-
graph are not a gold standard for measuring PA, they
have been shown to correlate well with doubly labelled
water to measure activity energy expenditure [15]. For
the Actigraph GT3X accelerometer, standard cut-points
for accelerometer counts per minute (CPM) for different
PA intensity categories have also been defined, thus lead-
ing to assessment of time spent in different PA inten-
sities: light 101–1951 CPM; moderate 1952–5724 CPM;
vigorous ≥5725 CPM [16].
Longitudinal studies and trials which examine PA
changes over time need valid, reliable PA assessment
methods. Both IPAQ-Short and accelerometry have been
used separately to measure PA change over time, [17–
20] but only a few small studies have used both and
compared change in minutes of PA [21, 22]. Other stud-
ies have compared self-report PA minutes with either
pedometer steps [23, 24] or accelerometry counts [25]
which are not directly comparable. The PACE-UP trial
offers the opportunity to directly compare change in PA
minutes from accelerometry and IPAQ within a large
trial dataset. This study had the following objectives: to
compare the trial treatment effects at 12 months (differ-
ence between intervention and control groups in the
change in PA) using (i) accelerometry minutes of MVPA
and IPAQ minutes of moderate+vigorous activity and
walking; (ii) the percentage of “active” individuals classi-
fied by accelerometry, IPAQ and GPPAQ.
Methods
Background to the PACE-UP study
The PACE-UP study is a three-arm parallel groups ran-
domised controlled trial comparing a 3-month
pedometer-based walking intervention, delivered by post
or with nurse support, to usual care [26]. Ethical ap-
proval was given by the London Research Ethics Com-
mittee (Hampstead) (12 L/LO/0219), trial registration
ISRCTN 98538934. Adults aged 45–75 years from seven
South-West London (UK) General Practices (family
practices) who self-reported as inactive were invited to
take part. Following a baseline assessment to assess eligi-
bility, 1023 participants gave informed written consent
and were randomised into one of three groups: the Con-
trol group (n = 338) received usual care; the Postal group
(n = 339) received a pedometer, a 12-week personalised
walking plan including behaviour change techniques
(e.g. goal setting, self-monitoring) designed to increase
their walking and a step-count diary through the post;
the Nurse group (n = 346) received these and were add-
itionally offered three individual practice nurse PA con-
sultations. Randomisation was carried out at household
level allowing couples to take part together. The main
trial outcomes were changes in accelerometry measured
average daily step-count and total weekly time in MVPA
in ≥10min bouts between baseline and 12months. 956/
1023 (93%) provided at least 1 day of accelerometry data
at 12 months, > 90% provided at least 5 days wear. The
postal and nurse groups both significantly increased
their objective PA levels (step count and time in MVPA)
compared with the control group, with no difference be-
tween intervention groups at 12 months [27].
Participants wore a sealed accelerometer (GT3X, Acti-
graph LLC) over their hip for 7 consecutive days at base-
line, prior to randomization, and 12months
post-randomization. They also completed the IPAQ
Short form [10] and GPPAQ [11], both designed for
self-completion, for the same 7-day periods as they wore
the accelerometer. Actilife software (v 6.6.0) was used to
extract and reduce the Actigraph data, ignoring runs of
≥60min of zero counts [26], to provide daily steps
counts and time spent in ≥10min bouts of MVPA
(≥1952 counts per minute, equivalent to ≥3 Metabolic
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Equivalents (METs)) [16]. When assessing ≥10 min bout,
the default “drop time” of 2 min was used, which allows
for a 2 min interruption in bout activity. At baseline, all
participants provided ≥5 days of ≥540 min accelerometer
wear-time. To limit attrition bias, those providing ≥1 day
of ≥540 min accelerometer wear time at 12 months were
included in analyses. IPAQ questions focus on time
spent being physically active in the previous 7 days in at
least 10 min bouts, including PA at work, home, travel-
ling and leisure. For each of vigorous and moderate PA
and walking, there are questions on the number of days
and the duration on each of these days. GPPAQ ques-
tions ask about PA at work and the type and weekly dur-
ation of leisure PA (physical exercise/sport, cycling,
walking, housework/childcare and gardening/DIY). Dur-
ation categories are None, < 1 h, 1–3 h, ≥3 h.
Study outcomes
Accelerometry
The main accelerometry outcome was total weekly mi-
nutes of MVPA in ≥10 min bouts; a secondary outcome
was total weekly minutes of MVPA, including MVPA in
< 10min bouts. Binary variables were generated for each
MVPA outcome to indicate 150 min of activity.
IPAQ
Total weekly minutes spent in each of vigorous PA,
moderate PA and walking were calculated, capped at a
maximum of 3 h/day or 21 h/week, as recommended by
the IPAQ coding guidelines [28]. Two self-report PA
measures were derived: total weekly minutes of vigorous
+ moderate PA in bouts of ≥10 min, excluding walking
(IPAQ-MVPA) and total weekly minutes of walking in
bouts of ≥10 min (IPAQ-Walk). We also report an add-
itional outcome, IPAQ-Total (IPAQ-MVPA +
IPAQ-Walk), conceptually the same construct as accel-
erometry MVPA in ≥10min bouts. Binary variables were
generated for each of these to indicate 150 min or more
per week of activity.
GPPAQ
The GPPAQ Physical Activity Index is a 4-level index
ranging from “Inactive” through to “Active”. “Active” in-
dividuals are achieving ≥3 h (180 min) of MVPA per
week including work PA and leisure PA from physical
exercise and cycling, but not including PA from walking,
housework/childcare or gardening. We defined a binary
outcome, GPPAQ, to identify those individuals classified
as “Active” by the GPPAQ score. However, adults who
are retired or not working and who do no sport or cyc-
ling can never be classified as active, although they may
achieve MVPA guidelines through walking. Thus, a
modified index, GPPAQ-Walk, was also derived, where
those who reported walking briskly for at least 3 h per
week were classified as “active”. Previous analysis of
GPPAQ showed this modified index had improved sensi-
tivity at identifying active individuals compared with
accelerometry data, but lower specificity in adults aged
60–75 years [29].
Statistical analyses
Analyses were carried out using Stata 14 [30].
Multi-level regression models estimated treatment ef-
fects for accelerometer, IPAQ and GPPAQ outcomes.
The 12-month outcome was regressed on baseline value,
treatment group, age, gender, practice and month of
baseline accelerometry as fixed effects and household as
a random effect in the multi-level model. (i) Linear re-
gression was used for weekly minutes of accelerometer
MVPA, IPAQ-MVPA, IPAQ-Walk and IPAQ-Total; (ii)
logistic regression was used for the binary variables “ac-
tive” from accelerometry, IPAQ and GPPAQ. The distri-
butions of change in PA for the four continuous
outcomes were reasonably normally distributed, as were
the distributions of residuals from the models, allowing
this method of analysis. Analyses were restricted to
those with complete data for all outcomes being com-
pared: 833 at baseline and 655 for the longitudinal re-
gression models. This ensured direct comparisons of the
same group of participants for each outcome. Sensitivity
analyses used ≥180min of accelerometer MVPA and
IPAQ outcomes, as the GPPAQ outcome is based on
≥180 min per week.
Results
At baseline, accelerometry data were available on all par-
ticipants and 989 (97%) returned IPAQ and GPPAQ
questionnaires. At 12 months, 956 (93%) participants
provided at least 1 day of accelerometry and 942 (92%)
returned IPAQ and GPPAQ questionnaires. However, in-
complete answers on IPAQ and GPPAQ questions re-
duced the sample size to 833 at baseline and to 655 for
analyses of changes between baseline and 12months.
Study groups were balanced at baseline for the 833 with
complete data with respect to age, gender, ethnicity and
different health measures (Table 1). One third of partici-
pants were male and two thirds were overweight or
obese (Body Mass Index ≥25 kg/m2). Mean weekly mi-
nutes of accelerometer-MVPA were 317 (sd 151) for
total MVPA and 98 (sd 103) for MVPA in ≥10 min
bouts. Self-reported mean weekly minutes were 174 (sd
279) for IPAQ-MVPA, 315 (sd 310) for IPAQ-Walk,
similar to total accelerometry MVPA and 489 (sd 453)
for IPAQ-Total. Accelerometry data classified 23% of
participants at baseline as “Active” i.e. achieving ≥150
min of MVPA per week in ≥10 min bouts (Table 1). In
contrast, 35, 66 and 84% of participants self-reported
≥150 min per week of IPAQ-MVPA, IPAQ-Walk and
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Table 1 Demographic, health, physical characteristics and physical activity at baseline
All groups
(N = 833)
Control
(N = 279)
Postal
(N = 270)
Nurse
(N = 284)
n (%) n (%) n (%) n (%)
Age at randomisation
45–54 years 280 (34%) 87 (31%) 94 (35%) 99 (35%)
55–64 years 315 (38%) 111 (40%) 98 (36%) 106 (37%)
65–75 years 238 (29%) 81 (29%) 78 (29%) 79 (28%)
Sex: Male 304 (36%) 98 (35%) 104 (39%) 102 (36%)
Ethnicity
White 654 (81%) 212 (79%) 222 (85%) 220 (80%)
Black / African / Caribbean / Black British 77 (10%) 25 (9%) 21 (8%) 31 (11%)
Asian / Asian British 54 (7%) 21 (8%) 14 (5%) 19 (7%)
Other, incl mixed 19 (2%) 10 (4%) 4 (2%) 5 (2%)
General health: Very good or good 679 (83%) 223 (81%) 230 (88%) 226 (82%)
Chronic diseases
None 321 (39%) 109 (39%) 112 (42%) 100 (36%)
1–2 436 (53%) 153 (55%) 133 (50%) 150 (54%)
≥ 3 61 (7%) 14 (5%) 20 (8%) 27 (10%)
Self-reported pain: Yes 566 (69%) 185 (67%) 191 (72%) 190 (69%)
Limiting long-standing illness 174 (21%) 60 (22%) 55 (21%) 59 (21%)
Townsend Disability score
None (0) 491 (60%) 159 (58%) 158 (59%) 174 (62%)
Slight or some disability (1–6) 305 (37%) 103 (37%) 104 (39%) 98 (35%)
Appreciable or severe disability (7–18) 24 (3%) 13 (5%) 4 (2%) 7 (3%)
Physical characteristics
Overweight/obese: BMI≥ 25 kg/m2 544 (65%) 184 (66%) 173 (64%) 187 (66%)
Mean (sd) Mean (sd) Mean (sd) Mean (sd)
Fat mass (kg) 26 (11) 26 (10) 26 (11) 26 (11)
Accelerometry data
Adjusted baseline step count per day 7550 (2670) 7528 (2685) 7480 (2583) 7638 (2744)
Total weekly mins MVPA in ≥10min bouts 98 (103) 91 (100) 97 (94) 106 (113)
Total weekly mins MVPA 317 (151) 316 (152) 311 (145) 322 (154)
Daily wear time (mins) 792 (79) 791 (73) 789 (79) 796 (84)
International Physical Activity Questionnaire (IPAQ)
IPAQ-MVPA: Weekly mins of moderate PA + vigorous PA in ≥10 min bouts 174 (279) 194 (310) 159 (266) 167 (259)
IPAQ-Walk: Weekly mins of walking in ≥10 min bouts 315 (310) 323 (327) 316 (326) 307 (275)
IPAQ-Total: Weekly mins of moderate PA + vigorous PA + walking in ≥10min bouts 489 (453) 518 (501) 475 (457) 474 (395)
n (%) n (%) n (%) n (%)
Proportions of “active” individualsa
Accelerometry
150 weekly mins MVPA in ≥10min bouts 190 (23%) 57 (21%) 58 (22%) 75 (27%)
International Physical Activity Questionnaire (IPAQ)
150 weekly mins of IPAQ-MVPA 286 (35%) 99 (36%) 86 (32%) 101 (36%)
150 weekly mins of IPAQ-Walk 540 (66%) 176 (64%) 173 (65%) 191 (68%)
150 weekly mins of IPAQ-Total 690 (84%) 227 (82%) 226 (85%) 237 (84%)
Limb et al. International Journal of Behavioral Nutrition and Physical Activity           (2019) 16:10 Page 4 of 11
IPAQ-Total respectively. GPPAQ classified 12% of par-
ticipants as active which increased to 28% when walking
was included.
i) Comparison of estimated treatment effects using
minutes of physical activity
Both intervention groups showed statistically significant
increases in accelerometer-MVPA, both in bouts and
total, compared with controls. Increases in
accelerometer-MVPA bouts: postal group 42min/week
(95% CI 22 to 61), nurse group 43 (95% CI 24 to 63)
(Table 2 and Fig. 1a); increases for total accelerometry
MVPA were almost identical to accelerometer-MVPA in
bouts but with wider confidence intervals (Table 2 and
Fig. 1). Repeating the analysis using the IPAQ outcomes,
IPAQ-Walk showed positive increases, similar in magni-
tude to accelerometer-MVPA in the nurse group, but
with wider confidence intervals indicating less precision:
postal group 57 min (95% CI 2 to 112), nurse group 43
(95% CI -11 to 97). IPAQ-MVPA showed non-significant
decreases and IPAQ-Total showed non-significant in-
creases. The distribution of residuals from the regression
models were normally distributed for MVPA in bouts
[27] and IPAQ outcomes (data not shown).
ii) Comparison of estimated treatment effects using the
binary variable “active”
Similar patterns were found for the binary variable “ac-
tive” for the different outcomes. Odds ratios (ORs) for
being “active” at 12 months (achieving ≥150 weekly mi-
nutes of MVPA in ≥10 min bouts) conditional on base-
line “active” status were statistically significant for
accelerometry-MVPA: postal group 3.7 (95% CI 1.8 to
7.5) and nurse group 2.9 (95% CI 1.5 to 5.7) (Table 3).
IPAQ-Walk showed statistically significant OR for the
postal group, 2.1 (95% CI 1.2 to 4.0) and borderline for
the nurse group, 1.7 (95% CI 1.0 to 3.0). Results were in-
conclusive for IPAQ-MVPA and IPAQ-Total had in-
creased ORs for both intervention groups, but only
statistically significant for the nurse group. ORs for the
two GPPAQ outcomes were close to 1.0 suggesting that
GPPAQ was unable to identify changes in the propor-
tion classified as “active” (Table 3). Sensitivity analyses
using ≥180 min of the accelerometer and IPAQ out-
comes gave similar results.
Discussion
The PACE-UP study was a walking intervention de-
signed to increase individuals’ PA through a 3-month
programme, in particular MVPA in ≥10min bouts in line
with current UK, WHO and US PA guidelines [31–33].
We found statistically significant increases between base-
line and 12months in accelerometer measured MVPA in
≥10min bouts for both intervention groups compared
with control. IPAQ-Walk showed a significant increase in
the postal group and a non-significant increase in the
nurse group compared with control, but with less preci-
sion than with accelerometry. IPAQ-MVPA showed
non-significant decreases and IPAQ-Total non-significant
increases in intervention groups compared with controls.
When considering the proportion of “active” individuals,
only accelerometry showed statistically significant in-
creases for both intervention groups versus controls.
IPAQ-Walk and IPAQ-Total showed statistically signifi-
cant increases for one intervention group compared with
controls (postal for IPAQ-Walk and nurse for
IPAQ-Total), but borderline effects for the other interven-
tion group compared with controls. Neither IPAQ-MVPA
nor GPPAQ identified any change in the proportions cate-
gorised as “active” in intervention versus control groups.
Therefore, in terms of overall construct validity for asses-
sing change in walking in a walking intervention study,
accelerometry has the greatest validity, followed by
IPAQ-Walk. The other measures have considerable disad-
vantages: IPAQ-MVPA and GPPAQ have very poor con-
struct validity; IPAQ-Total is measured with substantial
imprecision and is unsuitable for assessing a walking inter-
vention as it includes IPAQ-MVPA.
Our study had several strengths. It was based on a
large population-based sample of adults from seven
south-west London (UK) general practices (family prac-
tices), predominantly classified as inactive at baseline.
Accelerometry is an objective PA measure and measures
walking accurately. We used standard cut-points to de-
fine the different intensities of accelerometry activity and
were thus able to identify those bouts of walking which
can be classified as MVPA. The main PACE-UP analysis
Table 1 Demographic, health, physical characteristics and physical activity at baseline (Continued)
All groups
(N = 833)
Control
(N = 279)
Postal
(N = 270)
Nurse
(N = 284)
n (%) n (%) n (%) n (%)
General Practice Physical Activity Questionnaire (GPPAQ)
GPPAQ: “Active” ≥180 mins PA per week 101 (12%) 38 (14%) 33 (12%) 30 (11%)
GPPAQ-Walk: “Active” ≥180 mins PA per week including walking at brisk/fast pace 229 (28%) 82 (30%) 71 (27%) 76 (27%)
aProportions of “active” individuals are based on 276, 265 and 281 participants in Control, Postal and Nurse groups respectively
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[27] showed that the increase in weekly steps in inter-
vention groups relative to control group was equivalent
to the increase in weekly minutes of MVPA and this was
all in ≥10 min bouts, thus demonstrating the effective-
ness of the PACE-UP walking intervention. The two
self-completed questionnaires, IPAQ and GPPAQ, are
standard questionnaires used to assess PA, and were
completed for the same 7 days as for accelerometry, thus
providing directly comparable estimates of effect. The
study achieved 93% accelerometry follow-up at 12
months, > 90% of these with ≥5 days wear-time. Total
weekly minutes of MVPA and total weekly minutes of
walking (not including MVPA) were easy to extract from
IPAQ and provided a direct comparison with minutes of
accelerometer-MVPA. The increases in IPAQ-Walk mi-
nutes are similar to those for accelerometer-MVPA sug-
gesting that IPAQ can identify changes in walking
minutes, although the wider confidence intervals show
the loss of precision from using IPAQ. At baseline, aver-
age IPAQ-Walk minutes were similar to average total
accelerometer-MVPA minutes rather than
accelerometer-MVPA in ≥10min bouts. This is perhaps
unsurprising, as the IPAQ walking questions ask for
number of days walking and duration on each day, and
people may find it easier to report walking minutes as a
rounded number e.g. 30 or 45 min per day and which
may include relative short walks of < 10 min. GPPAQ is
commonly used in UK general practice to assess an indi-
vidual’s PA. However, it can underestimate PA amongst
those not working or those whose main PA is walking,
and this study provided a further opportunity to evaluate
our modified GPPAQ–Walk index [29]. We were also
able to estimate how well GPPAQ could identify individ-
uals moving from “not active” to “active” (assumed to be
achieving PA guidelines). Finally, our method of analysis,
regressing outcome at 12 months on baseline values
focusses on individual changes in activity while allowing
for regression to the mean. Cross-sectionally, the distri-
butions of accelerometer-MVPA and IPAQ measures are
highly skewed leading many to present medians and
interquartile ranges of activity at different time points.
However, change in activity is usually symmetric and
reasonably normally distributed, which our approach ex-
ploits. We were thus able to present mean changes in
activity and associated confidence intervals for both
accelerometry and questionnaire measures, thus allow-
ing for a more informative comparison.
The study also had some important limitations. All of
the PA measures (accelerometry, IPAQ and GPPAQ)
only measured PA levels for 7 days and it may be that
participants were more likely to be active or report being
active in the week that their PA was being assessed, ra-
ther than at other times. However, any such tendency
would potentially affect all of the PA measures and
would be true for control participants as well as for
those in the intervention group. IPAQ is difficult to
complete and thus unreliable if an individual’s PA varies
by day across the week. Although we had high return
rates at baseline and 12months for the IPAQ and
GPPAQ, 97% and 92% respectively, each IPAQ outcome
at baseline and 12 months had 20–25% missing or in-
complete answers. Participants’ comments on the ques-
tionnaires described their confusion over how to
interpret and answer the questions and many questions
were left blank. This reduced our sample size to 655 for
comparisons with accelerometry although this is still
large compared with other studies [21–23]. The propor-
tions of missing data were similar across the three
groups, but those with missing IPAQ data had lower
mean accelerometry-MVPA at baseline and 12months
than those with complete data. The accelerometry effect
sizes reported here (42–43 min) are also larger than for
the full cohort (33–35min) [27]. The limited options on
GPPAQ for duration of PA, led to using ≥3 h (180 min)
for GPPAQ “active” whereas the PA guidelines are ≥150
min. However, ORs from sensitivity analyses using ≥180
min for accelerometry and IPAQ outcomes were similar
to those using ≥150 min. Although neither of our
methods of measuring PA are considered a
gold-standard, accelerometry has the advantage of pro-
viding an objective time-stamped record of PA that does
not rely on recall. It has been validated as a measure of
activity energy expenditure using doubly labelled water
[15] and we used standard cut-points in counts per mi-
nute to define MVPA. [16] Our findings that
accelerometer-MVPA and IPAQ-Walk provide similar
estimates of change clearly support results from the
PACE-UP intervention which is aimed at increasing
walking, but it is unknown if these findings would be
generalisable to other PA interventions.
Fig. 1 Treatment effects and 95% confidence intervals for change in
minutes of physical activity measured by accelerometry, IPAQ-MVPA,
IPAQ-Walk and IPAQ-Total
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Participants in the postal and nurse intervention
groups were encouraged to increase their MVPA
through walking and the nurse group in particular were
taught to recognise and classify different PA intensities
– vigorous, moderate, light, and sedentary. Thus they
may have been more likely to accurately report their PA
on IPAQ at follow-up i.e. with less over-estimation of
their PA levels, which could explain the non-significant
decreases in the treatment groups for IPAQ-MVPA from
the modelling.
Comparison with other studies
Our baseline data agree with other studies that individ-
uals tend to over-estimate their PA on self-report ques-
tionnaires compared with objective accelerometry, both
time spent being physically active [6] and proportions
achieving PA guidelines [7]. Studies which have found
better correspondence between IPAQ and accelerometry
cross-sectionally [34] have used total accelerometer
MVPA rather than MVPA in ≥10min bouts and a simi-
lar pattern is seen in our data where baseline total
accelerometer-MVPA minutes are similar to IPAQ-Walk
minutes. However, IPAQ questions ask about vigorous
and moderate PA in ≥10 min bouts and UK, WHO and
US PA guidelines are based on ≥150 min of MVPA per
week in ≥10 min bouts. In our trial, whilst total accelero-
metry MVPA was much higher than accelerometry
MVPA in ≥10min bouts, changes in both measures were
almost identical.
To our knowledge, this is the largest population-based
trial to make direct comparisons of accelerometry and
self-report questionnaires to assess an individual’s change
in minutes of PA after an intervention. There are limita-
tions with all five studies we identified [21–25] which have
attempted to compare longitudinal changes in PA mea-
sured using IPAQ compared with objective measures.
Three studies recruited less than 100 subjects [21–23].
One study was observational [21], one had no control
group [22] and one was a weight loss intervention rather
than PA intervention [24]. One study was comparing
IPAQ with pedometer steps [23] and another with acceler-
ometer counts [25] making direct comparison of minutes
of physical activity between IPAQ and accelerometry diffi-
cult. Whilst our study compares measures using different
constructs, we were able to compare time spent in MVPA
and time spent walking, both in minutes per week. Three
studies present distribution of PA measures at baseline
and follow-up, but provided no estimate of the distribu-
tion of change [21, 24, 25]. Our findings do agree with
two of the small studies. Nicaise et al. [22] followed up
one group of women, but with no control group, and
found median changes in IPAQ Walking minutes were
similar to median changes in accelerometer MVPA mi-
nutes. Baker et al. [23] compared IPAQ PA minutes with
pedometer steps, and argue that the increase in step
counts in the intervention group was comparable to the
increase in leisure time walking reported on IPAQ, al-
though they report mean differences for pedometer steps
and median differences for IPAQ data.
GPPAQ is used in UK primary care to help identify
those not achieving PA guidelines during UK NHS
Health Checks [12]. GPPAQ guidance recommends re-
peating it annually on those at increased cardiovascular
risk [11], but our study suggests that it is poor at identi-
fying those individuals who have increased their PA to
current guideline levels. In addition, the binary nature of
this outcome fails to recognise modest, but important,
increases in PA made by inactive individuals. We have
also confirmed our previous findings [29] that, com-
pared with objective accelerometry, GPPAQ underesti-
mates the proportion of “active” individuals and our
modified index GPPAQ-Walk classifies slightly more as
“active”.
Conclusions
We have demonstrated that neither GPPAQ nor
IPAQ-MVPA provide a valid estimate of change in a
walking intervention trial compared with accelerometry
measures. Moreover, we have shown that although
IPAQ-Walk produces an estimate of change comparable
with that from accelerometry MVPA in ≥10min bouts,
the IPAQ-Walk estimate had considerably less precision.
Missing data were also an issue with the self-report
IPAQ. This has implications for future trials. Studies
may need to use IPAQ to assess changes in walking if
they are not able to use accelerometry. If this is the case,
they should focus particularly on the walking questions
and will need to be larger to be adequately powered, al-
though they will still lack information on intensity of
any changes that occur. In conclusion, accelerometry is
preferred to self-report measures in assessing the effects
of a walking intervention, as it avoids recall bias and im-
proves precision.
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